摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-chlorophenyl)-N′-(4-pyridinyl)urea | 13208-60-1

中文名称
——
中文别名
——
英文名称
N-(4-chlorophenyl)-N′-(4-pyridinyl)urea
英文别名
N-(4-pyridyl)-N'-(4-chlorophenyl)urea;1-(4-chloro-phenyl)-3-pyridin-4-yl-urea;N-(4-Chlor-phenyl)-N'-(4-pyridyl)-harnstoff;1-(4-Chlorophenyl)-3-(pyridin-4-yl)urea;1-(4-chlorophenyl)-3-pyridin-4-ylurea
N-(4-chlorophenyl)-N′-(4-pyridinyl)urea化学式
CAS
13208-60-1
化学式
C12H10ClN3O
mdl
MFCD00579616
分子量
247.684
InChiKey
AAVUKLGYVIGYKQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    308.4±22.0 °C(Predicted)
  • 密度:
    1.415±0.06 g/cm3(Predicted)
  • 溶解度:
    9.8 [ug/mL]

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    54
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    对氯苯异氰酸酯 以94%的产率得到
    参考文献:
    名称:
    VASILEV, GEORGI NIKOLOV;JONOVA, PETRANKA ANGELOVA
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Substituent effect of <i>N</i> -aryl-<i>N</i> ′-pyridyl ureas as thermal latent initiators on ring-opening polymerization of epoxide
    作者:Naoyuki Makiuchi、Atsushi Sudo、Takeshi Endo
    DOI:10.1002/pola.27726
    日期:2015.11.15
    series of N‐aryl‐N′‐pyridyl ureas were synthesized by the reactions of 4‐aminopyridine (4AP) with the corresponding isocyanates such as phenyl isocyanate, 4‐methylphenyl isocyanate, 4‐methoxyphenyl isocyanate, 4‐chlorophenyl isocyanate, 4‐(trifluoromethyl)phenyl isocyanate, and 4‐nitrophenyl isocyanate. Bulk polymerization of diglycidyl ether of bisphenol A (DGEBA) in the presence of the ureas as initiators
    一系列ñ -芳基- ñ “ -吡啶基脲由4-氨基吡啶(4AP)的与相应的异氰酸酯的反应,如异氰酸苯酯,4-甲基苯基异氰酸酯,4-甲氧基苯基异氰酸酯,4合成-氯苯基异氰酸酯,4 - (三氟甲基)苯基异氰酸酯和4-硝基苯基异氰酸酯。通过差示扫描量热法(DSC)以10℃/ min的加热速率评价在作为引发剂的脲存在下的双酚A的二缩水甘油醚(DGEBA)的本体聚合。所得的DSC谱图表明高于140°C的放热峰,而由DGEBA和原始4AP组成的制剂测得的DSC谱图表明在120°C附近有放热峰,这表明将4AP衍生为相应的尿素是一种有用的策略达到热潜伏期。最高峰温度与脲类芳香环的电子密度相关,也就是说,随着芳香环上取代基的吸电子性质变大,峰会增加。©2015 Wiley Periodicals,Inc. J. Polym。科学,A部分:Polym。2015年,53,2569年至2574年
  • Phosgene-free synthesis of N-aryl-N'-4-pyridinylureas via selenium-catalyzed oxidative carbonylation of 4-aminopyridine with aromatic amines
    作者:Xiaopeng Zhang、Zhengwei Li、Yan Wang、Shuxiang Dong、Xueli Niu、Guisheng Zhang
    DOI:10.3998/ark.5550190.p009.683
    日期:——
    atom economy has been developed for the synthesis of N-aryl-N′-(4-pyridinyl)ureas. With cheap selenium as the catalyst, carbon monoxide (instead of phosgene) as the carbonyl reagent, N-aryl-N′-(4-pyridinyl)ureas can be obtained in a one-pot manner mostly in moderate to good yields via oxidative cross-carbonylation of 4-aminopyridine with a variety of aromatic amines in the presence of oxygen under atmospheric
    已开发出一种简便、无光气且具有高原子经济性的方法来合成 N-芳基-N'-(4-吡啶基)脲。以廉价的硒为催化剂,以一氧化碳(而不是光气)为羰基试剂,可以通过氧化交叉以一锅法获得N-芳基-N'-(4-吡啶基)脲,大部分收率中等至良好- 4-氨基吡啶与多种芳香胺在氧气存在下在大气压下羰基化。还提出了合成N-芳基-N'-(4-吡啶基)脲的机理。
  • N-Phenyl-N'-pyridinylureas as anticonvulsant agents
    作者:Michael R. Pavia、Sandra J. Lobbestael、Charles P. Taylor、Fred M. Hershenson、David L. Miskell
    DOI:10.1021/jm00164a061
    日期:1990.2
    A series of N-phenyl-N'-pyridinylureas was examined for anticonvulsant activity. Extensive structure/activity investigations revealed optimal activity in the N-(2,6-disubstituted-phenyl)-N'-(4-pyridinyl)urea series, with 37 exhibiting the best overall anticonvulsant profile. Compound 37 was effective against seizures induced by maximal electroshock but did not protect mice from clonic seizures produced by the convulsant pentylenetetrazol. The overall pharmacological profile suggests that 37 would be of therapeutic use in the treatment of generalized tonic-clonic and partial seizures. Compound 37 was selected for Phase 1 clinical trials.
  • Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
    申请人:Tao Chunlin
    公开号:US20120270858A1
    公开(公告)日:2012-10-25
    The invention provides isoquinoline, quinoline, and quinazoline derivatives to treat a variety of disorders, diseases and pathologic conditions, and more specifically to the use of isoquinoline, quinoline, and quinazoline derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds to the treatment of hyperproliferative diseases and pathologic angiogenesis.
  • VASILEV, GEORGI NIKOLOV;JONOVA, PETRANKA ANGELOVA
    作者:VASILEV, GEORGI NIKOLOV、JONOVA, PETRANKA ANGELOVA
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐